Meribank Biotech Co., Ltd (TPEX:4724)
Taiwan · Delayed Price · Currency is TWD 16.15
-0.15 (-0.92%)
Jul 21, 2025, 11:25 AM CST
Meribank Biotech Market Cap
Meribank Biotech has a market cap or net worth of 1.43 billion as of July 18, 2025. Its market cap has decreased by -47.18% in one year.
Market Cap
1.43B
Enterprise Value
2.22B
Revenue
366.43M
Ranking
n/a
PE Ratio
n/a
Stock Price
16.15
Market Cap Chart
Since June 16, 2023, Meribank Biotech's market cap has decreased from 1.95B to 1.43B, a decrease of -26.31%. That is a compound annual growth rate of -13.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 18, 2025 | 1.43B | -41.79% |
| Dec 31, 2024 | 2.46B | 2.99% |
| Dec 29, 2023 | 2.39B | 22.90% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 188.45B |
| PharmaEssentia | 182.63B |
| Bora Pharmaceuticals Co., LTD. | 87.20B |
| Lotus Pharmaceutical | 58.11B |
| Oneness Biotech | 30.90B |
| Polaris Group | 29.16B |
| Center Laboratories | 26.75B |
| TaiMed Biologics | 23.84B |